glp-1 medications approved for diabetes and weight loss 2025 Blockbuster Drugs Fails in Alzheimer's Trial GLP-1 medications compared: Benefits and

Description

Clinical trials for GLP-1 agonists have found that nausea occurs in 15% to 30% of patients, diarrhea in 10-15%, and vomiting in 5-10% (usually as a result of the nausea)

Certain people also have a hormonal imbalance that can affect their level of hunger and make it difficult to lose weight, despite healthy lifestyle practices

However, the study found compared to the placebo group: Participants treated with semaglutide exhibited a broad pattern of slower biological aging across epigenetic clocks linked to inflammation and blood, brain, heart, kidney, liver and metabolic health

If significant weight loss is not achieved after 16 weeks, your Centra Internal Medicine provider will reassess your treatment plan and discuss next steps with you